Provide data science services to help biotech/pharma clients solve problems in drug discovery and diagnostics development, including platform establishment/industrialization, target ID/validation, therapy characterization and optimization, response biomarker and PD marker discovery. We use proprietary biomedical knowledge graph, NLP and ML/DL to identify novel targets, repurpose drugs, design drug combinations and predict side effects, among others.Exemplary Projects Accomplished:-- Platform building for a platform biotech startup to convert academic single-cell innovation to first-in-class target discovery engine, as acting Chief Data Officer-- Building data science function for a clinical-stage biotech client, as Head of Data Science-- Data science strategy consulting for biotech AI startups, as Industry Expert/Mentor-- RWD analysis for multiple clinical-stage biotech clients, that advanced response biomarker discovery, facilitated patient recruitment and optimized therapy manufacturing process-- designing translational research plan for clinical drug candidates-- AI platform building for a biotech AI startup, as acting Chief Data Officer

Oversee bioinformatics and computational biology research to support client projects, establish end-to-end service offerings for RNA therapeutics and PROTAC development, and create new business models to enable WuXi asset generation.

Utilize ML/AI algorithms on NGS, multi-omics data and RWE in conjunction with network biology analysis to derive insight from high-dimensional data, to drive precision medicine R&D Forward.

Head of data science, building the data analytics function to match patients to novel therapeutics as well as to discover new drug targets through applying state-of-the-art ML/AI algorithms on 'omics and functional HTS data generated on patient biopsies.

Computational biology lead for AG-270 translational research, AG-270 IND filing and exploratory oncology research. Predictive modeling. Patient stratification. MoE investigation. Response biomarker discovery. Synergy prediction. Drug combination strategy creation.

Lead computational biologist in multiple therapeutic areas, including inflammatory/autoimmune diseases, oncology, rare genetic disorders and infectious diseases.